157 related articles for article (PubMed ID: 10951695)
1. Expression and immune recognition of SV40 Tag in transgenic mice that develop metastatic osteosarcomas.
Marton I; Johnson SE; Damjanov I; Currier KS; Sundberg JP; Knowles BB
Transgenic Res; 2000 Apr; 9(2):115-25. PubMed ID: 10951695
[TBL] [Abstract][Full Text] [Related]
2. Osteosarcomas in transgenic mice expressing an alpha-amylase-SV40 T-antigen hybrid gene.
Knowles BB; McCarrick J; Fox N; Solter D; Damjanov I
Am J Pathol; 1990 Aug; 137(2):259-62. PubMed ID: 2386195
[TBL] [Abstract][Full Text] [Related]
3. Timely immunization subverts the development of peripheral nonresponsiveness and suppresses tumor development in simian virus 40 tumor antigen-transgenic mice.
Ye X; McCarrick J; Jewett L; Knowles BB
Proc Natl Acad Sci U S A; 1994 Apr; 91(9):3916-20. PubMed ID: 8171012
[TBL] [Abstract][Full Text] [Related]
4. Control of advanced choroid plexus tumors in SV40 T antigen transgenic mice following priming of donor CD8(+) T lymphocytes by the endogenous tumor antigen.
Schell TD; Tevethia SS
J Immunol; 2001 Dec; 167(12):6947-56. PubMed ID: 11739514
[TBL] [Abstract][Full Text] [Related]
5. Sequential loss of cytotoxic T lymphocyte responses to simian virus 40 large T antigen epitopes in T antigen transgenic mice developing osteosarcomas.
Schell TD; Knowles BB; Tevethia SS
Cancer Res; 2000 Jun; 60(11):3002-12. PubMed ID: 10850449
[TBL] [Abstract][Full Text] [Related]
6. Cytotoxic T-lymphocyte epitope immunodominance in the control of choroid plexus tumors in simian virus 40 large T antigen transgenic mice.
Schell TD; Mylin LM; Georgoff I; Teresky AK; Levine AJ; Tevethia SS
J Virol; 1999 Jul; 73(7):5981-93. PubMed ID: 10364350
[TBL] [Abstract][Full Text] [Related]
7. SV40 T antigen acts as a minor histocompatibility antigen of SV40 T antigen tolerant transgenic mice.
Juretic A; Knowles BB
Immunogenetics; 1989; 29(6):366-70. PubMed ID: 2786497
[TBL] [Abstract][Full Text] [Related]
8. CD4+ T lymphocytes play a critical role in antibody production and tumor immunity against simian virus 40 large tumor antigen.
Kennedy RC; Shearer MH; Watts AM; Bright RK
Cancer Res; 2003 Mar; 63(5):1040-5. PubMed ID: 12615720
[TBL] [Abstract][Full Text] [Related]
9. Lactation-induced WAP-SV40 Tag transgene expression in C57BL/6J mice leads to mammary carcinoma.
Hüsler MR; Kotopoulis KA; Sundberg JP; Tennent BJ; Kunig SV; Knowles BB
Transgenic Res; 1998 Jul; 7(4):253-63. PubMed ID: 9859214
[TBL] [Abstract][Full Text] [Related]
10. Development and Preclinical Application of an Immunocompetent Transplant Model of Basal Breast Cancer with Lung, Liver and Brain Metastases.
Aprelikova O; Tomlinson CC; Hoenerhoff M; Hixon JA; Durum SK; Qiu TH; He S; Burkett S; Liu ZY; Swanson SM; Green JE
PLoS One; 2016; 11(5):e0155262. PubMed ID: 27171183
[TBL] [Abstract][Full Text] [Related]
11. Frequency of SV40-specific cytotoxic T-lymphocyte precursors in two SV40 T-antigen transgenic mouse lines.
Juretic A; Knowles BB
APMIS; 1991 Mar; 99(3):213-8. PubMed ID: 1850285
[TBL] [Abstract][Full Text] [Related]
12. Partially circumventing peripheral tolerance for oncogene-specific prostate cancer immunotherapy.
Neeley YC; Arredouani MS; Hollenbeck B; Eng MH; Rubin MA; Sanda MG
Prostate; 2008 May; 68(7):715-27. PubMed ID: 18302222
[TBL] [Abstract][Full Text] [Related]
13. Simian virus 40 (SV40)-transgenic mice that develop tumors are specifically tolerant to SV40 T antigen.
Faas SJ; Pan S; Pinkert CA; Brinster RL; Knowles BB
J Exp Med; 1987 Feb; 165(2):417-27. PubMed ID: 3029269
[TBL] [Abstract][Full Text] [Related]
14. Tumor immunity against a simian virus 40 oncoprotein requires CD8+ T lymphocytes in the effector immune phase.
Lowe DB; Shearer MH; Jumper CA; Bright RK; Kennedy RC
J Virol; 2010 Jan; 84(2):883-93. PubMed ID: 19889780
[TBL] [Abstract][Full Text] [Related]
15. Clonal deletion of simian virus 40 large T antigen-specific T cells in the transgenic adenocarcinoma of mouse prostate mice: an important role for clonal deletion in shaping the repertoire of T cells specific for antigens overexpressed in solid tumors.
Zheng X; Gao JX; Zhang H; Geiger TL; Liu Y; Zheng P
J Immunol; 2002 Nov; 169(9):4761-9. PubMed ID: 12391185
[TBL] [Abstract][Full Text] [Related]
16. Accumulation of CD8+ T cells in advanced-stage tumors and delay of disease progression following secondary immunization against an immunorecessive epitope.
Ryan CM; Schell TD
J Immunol; 2006 Jul; 177(1):255-67. PubMed ID: 16785521
[TBL] [Abstract][Full Text] [Related]
17. Differential presentation of endogenously processed cytotoxic T lymphocyte epitopes by mouse hepatocarcinoma cell lines induced by SV40 large T antigen.
Lacabanne V; Viguier M; Romieu R; Kayibanda M; Connan F; Sermet S; Antoine B; Guillet JG; Choppin J
Int Immunol; 1998 Apr; 10(4):463-72. PubMed ID: 9620602
[TBL] [Abstract][Full Text] [Related]
18. Peripheral T cell tolerance occurs early during spontaneous prostate cancer development and can be rescued by dendritic cell immunization.
Degl'Innocenti E; Grioni M; Boni A; Camporeale A; Bertilaccio MT; Freschi M; Monno A; Arcelloni C; Greenberg NM; Bellone M
Eur J Immunol; 2005 Jan; 35(1):66-75. PubMed ID: 15597325
[TBL] [Abstract][Full Text] [Related]
19. Expression of a fusion gene consisting of the mouse growth hormone-releasing hormone gene promoter linked to the SV40 T-antigen gene in transgenic mice.
Nogues N; Magnan E; De Grandis P; Butz M; Kineman RD; Kopchick JJ; Frohman LA
Mol Cell Endocrinol; 1998 Feb; 137(2):161-8. PubMed ID: 9605518
[TBL] [Abstract][Full Text] [Related]
20. Simian virus 40 large-T-antigen-specific rejection of mKSA tumor cells in BALB/c mice is critically dependent on both strictly tumor-associated, tumor-specific CD8(+) cytotoxic T lymphocytes and CD4(+) T helper cells.
Utermöhlen O; Schulze-Garg C; Warnecke G; Gugel R; Löhler J; Deppert W
J Virol; 2001 Nov; 75(22):10593-602. PubMed ID: 11602701
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
